Industry: Pharmaceuticals, Biotechnology
Isolagen specializes in the development and commercialization of autologous cellular therapies for soft and hard tissue regeneration. The company’s product candidates are based on its proprietary Isolagen Process. Based on the accumulated experience of the company through its retrospective study, clinical trials and treatment of patients in the United Kingdom, the company believes that the Isolagen Process utilizes the patient’s own cells to create safe and effective therapies to treat the underlying cause of the patient’s condition. Autologous cellular therapy is the process whereby a patient’s own cells are extracted, allowed to multiply and then injected into the patient. Isolagen’s product candidates are designed to be minimally invasive and non-surgical. ( www.isolagen.com )
Isolagen , Inc.
405 Eagleview Boulevard
Exton, Pennsylvania 19341
USA
Tel: (484) 713-6000
Fax: (484) 713-6001